‌

US Patent 10967011 Compositions and methods

Patent 10967011 was granted and assigned to Seres Therapeutics on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Seres Therapeutics

0

Current Assignee

Seres Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mary-Jane Lombardo McKenzie0

Matthew R. Henn0

Brian Goodman0

David Arthur Berry0

David N. Cook0

Geoffrey von Maltzahn0

Gregory McKenzie0

John Grant Aunins0

...

Date of Patent

April 6, 2021

0

Patent Application Number

160548640

Date Filed

August 3, 2018

0

Patent Citations

US Patent 10064901 Compositions and methods

Patent Citations Received

US Patent 12083151 Synergistic bacterial compositions and methods of production and use thereof

0

US Patent 11458174 Synergistic bacterial compositions and methods of production and use thereof

US Patent 11464812 Synergistic bacterial compositions and methods of production and use thereof

0

US Patent 11666612 Network-based microbial compositions and methods

0

US Patent 11701394 Compositions and methods for treating cholestatic disease

0

US Patent 11458173 Synergistic bacterial compositions and methods of production and use thereof

0

Patent Primary Examiner

Albert M Navarro

0

Patent abstract

Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10967011 Compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.